Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s13062-016-0135-4.

Title:
Stem-like features of cancer cells on their way to metastasis | Biology Direct
Description:
Abstract More than 90 % of cancer-related deaths are due to the development of a systemic metastatic disease. Clearly, much remains to be understood about the biological principles that govern human cancer metastasis, aiming at the ambitious objective to decrease metastasis-related mortality in patients. For many years, research on metastasis has been conducted in great part on experimental mouse models, mainly because of the difficulties in sampling, longitudinal studies, and molecular interrogation of a human metastatic disease. However, recently, extraordinary advances in microfluidic technologies are allowing the isolation and characterization of human circulating tumor cells (CTCs) that escaped a primary tumor mass and are in the process of seeding a distant metastasis. Analysis of human CTCs has now revealed important features of cancer metastasis, such as the high metastatic potential of CTC-clusters compared to single CTCs, the dynamic expression of epithelial and mesenchymal markers on CTCs during treatment, and the possibility to culture CTCs from patients for a real-time and individualized testing of drug susceptibility. Nevertheless, several aspects of CTC biology remain unsolved, such as the characterization of the stem-like cell population among human CTCs. Here, we focus on describing the latest findings in the CTC field, and discuss them in the context of cancer stem cell biology. Defining the molecular features of those few metastasis-initiating, stem-like CTCs holds the exceptional promise to develop metastasis-tailored therapies for patients with cancer. Reviewers This article was reviewed by Elisa Cimetta, Luca Pellegrini and Sirio Dupont (nominated by LP).
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cells, cancer, ctcs, pubmed, cell, article, google, scholar, stemlike, ctc, stem, tumor, cas, authors, patients, human, metastatic, metastasis, expression, response, single, blood, clusters, breast, circulating, properties, central, markers, studies, potential, reviewer, population, tumors, features, mouse, epithelial, conditions, isolation, heterogeneity, line, page, biology, circulation, shown, molecular, culture, enriched, review, disease, text,

Topics {✒️}

anti-pd-l1 blocking antibody anti-pd-l1 antibody mpdl3280a article download pdf phosphatidylinositol 3-kinase/akt/mammalian target microvortex-generating herringbone-chip human colon-cancer-initiating cells mek/erk/tsc2 pathway multi-lineage mammary tumours anti-cancer immunotheraphy strategies wnt-driven mammary tumorigenesis decrease metastasis-related mortality develop metastasis-tailored therapies transforming growth factor-β serum-free media supplemented pharmacological gsk-3-specific inhibitor pten/mtor/stat3 pathway bona fide stem embryo-derived stem cells initiating tumour growth mitogen-activated protein kinase metastasis-initiating cell population filter-based platforms small-cell lung cancer cd44+/cd24- phenotype relates cancer stem cells—perspectives immune cells-rich environment size-based microfluidic device cancer-stem cell traits article gkountela cancer stem/progenitor cells pd1/pd-l1 interaction pd-l1/pd1 interaction decreased metastasis-free survival release adenine nucleotides metastasis-initiating cells remains multi-step evolutionary process fine-tune malignant properties tumor microenvironment putative stem-cell markers cell search system short circulation half-life �triple-negative’ state poor metastasis-free survival size-based approaches mentioned acute myeloid leukemia hou jm krebs mg cell-cell adhesion nicola aceto mda-mb-231 cells

Questions {❓}

  • 4, from line 23 on): could the authors comment on the potential effects (membrane damages, pathways activation, etc) elicited by shear forces on the exposed cells?
  • 8, from line 41 on): could this be linked to the fact that CTCs clusters appear to be enriched in stem-like cells?
  • Can certain genetic or epigenetic signatures promote stem-like features and are these signatures enriched in a subset of CTCs?
  • Circulating tumor cell enumeration by the cell search system: the clinician’s guide to breast cancer treatment?
  • How then these different aspects would merge in the case of CTC clusters?
  • Minor issues: Page8, line 58: “we shown” should maybe be “were shown”?
  • Page 4, line 18: clarify if this is the size of single or clustered CTC?
  • Page 5: What can we learn, or at least estimate, on human disease from the CTC half-life in mice and the observed CTC frequencies in human patients?
  • Page 5: was the correlation between cluster CTC and malignancy observed in human cancer patients corrected for the grade/burden of the primary tumor?
  • Please also remember that LGR5 was isolated as a normal stem cell marker based on the hypothetical assumption that cancer cells recapitulate traits of the physiologic stem cell (VanDeWetering and Clevers original paper), but how many of the physiological stem cell markers identified thereafter do follow this rule and are also found in cancer stem cell populations?
  • To which extent a homogeneous system like MDA-LM2 is informative on heterogeneous cancer populations containing both stem and non-stem cancer cells?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Stem-like features of cancer cells on their way to metastasis
         description:More than 90 % of cancer-related deaths are due to the development of a systemic metastatic disease. Clearly, much remains to be understood about the biological principles that govern human cancer metastasis, aiming at the ambitious objective to decrease metastasis-related mortality in patients. For many years, research on metastasis has been conducted in great part on experimental mouse models, mainly because of the difficulties in sampling, longitudinal studies, and molecular interrogation of a human metastatic disease. However, recently, extraordinary advances in microfluidic technologies are allowing the isolation and characterization of human circulating tumor cells (CTCs) that escaped a primary tumor mass and are in the process of seeding a distant metastasis. Analysis of human CTCs has now revealed important features of cancer metastasis, such as the high metastatic potential of CTC-clusters compared to single CTCs, the dynamic expression of epithelial and mesenchymal markers on CTCs during treatment, and the possibility to culture CTCs from patients for a real-time and individualized testing of drug susceptibility. Nevertheless, several aspects of CTC biology remain unsolved, such as the characterization of the stem-like cell population among human CTCs. Here, we focus on describing the latest findings in the CTC field, and discuss them in the context of cancer stem cell biology. Defining the molecular features of those few metastasis-initiating, stem-like CTCs holds the exceptional promise to develop metastasis-tailored therapies for patients with cancer. This article was reviewed by Elisa Cimetta, Luca Pellegrini and Sirio Dupont (nominated by LP).
         datePublished:2016-07-26T00:00:00Z
         dateModified:2016-07-26T00:00:00Z
         pageStart:1
         pageEnd:14
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13062-016-0135-4
         keywords:
            Cancer metastasis
            Circulating tumor cells
            CTCs
            CTC clusters
            Stem-like features
            Life Sciences
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13062-016-0135-4/MediaObjects/13062_2016_135_Fig1_HTML.gif
         isPartOf:
            name:Biology Direct
            issn:
               1745-6150
            volumeNumber:11
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sofia Gkountela
               affiliation:
                     name:Cancer Metastasis, University of Basel
                     address:
                        name:Department of Biomedicine, Cancer Metastasis, University of Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nicola Aceto
               url:http://orcid.org/0000-0001-9579-6918
               affiliation:
                     name:Cancer Metastasis, University of Basel
                     address:
                        name:Department of Biomedicine, Cancer Metastasis, University of Basel, Basel, Switzerland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Stem-like features of cancer cells on their way to metastasis
      description:More than 90 % of cancer-related deaths are due to the development of a systemic metastatic disease. Clearly, much remains to be understood about the biological principles that govern human cancer metastasis, aiming at the ambitious objective to decrease metastasis-related mortality in patients. For many years, research on metastasis has been conducted in great part on experimental mouse models, mainly because of the difficulties in sampling, longitudinal studies, and molecular interrogation of a human metastatic disease. However, recently, extraordinary advances in microfluidic technologies are allowing the isolation and characterization of human circulating tumor cells (CTCs) that escaped a primary tumor mass and are in the process of seeding a distant metastasis. Analysis of human CTCs has now revealed important features of cancer metastasis, such as the high metastatic potential of CTC-clusters compared to single CTCs, the dynamic expression of epithelial and mesenchymal markers on CTCs during treatment, and the possibility to culture CTCs from patients for a real-time and individualized testing of drug susceptibility. Nevertheless, several aspects of CTC biology remain unsolved, such as the characterization of the stem-like cell population among human CTCs. Here, we focus on describing the latest findings in the CTC field, and discuss them in the context of cancer stem cell biology. Defining the molecular features of those few metastasis-initiating, stem-like CTCs holds the exceptional promise to develop metastasis-tailored therapies for patients with cancer. This article was reviewed by Elisa Cimetta, Luca Pellegrini and Sirio Dupont (nominated by LP).
      datePublished:2016-07-26T00:00:00Z
      dateModified:2016-07-26T00:00:00Z
      pageStart:1
      pageEnd:14
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13062-016-0135-4
      keywords:
         Cancer metastasis
         Circulating tumor cells
         CTCs
         CTC clusters
         Stem-like features
         Life Sciences
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13062-016-0135-4/MediaObjects/13062_2016_135_Fig1_HTML.gif
      isPartOf:
         name:Biology Direct
         issn:
            1745-6150
         volumeNumber:11
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sofia Gkountela
            affiliation:
                  name:Cancer Metastasis, University of Basel
                  address:
                     name:Department of Biomedicine, Cancer Metastasis, University of Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nicola Aceto
            url:http://orcid.org/0000-0001-9579-6918
            affiliation:
                  name:Cancer Metastasis, University of Basel
                  address:
                     name:Department of Biomedicine, Cancer Metastasis, University of Basel, Basel, Switzerland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Biology Direct
      issn:
         1745-6150
      volumeNumber:11
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Metastasis, University of Basel
      address:
         name:Department of Biomedicine, Cancer Metastasis, University of Basel, Basel, Switzerland
         type:PostalAddress
      name:Cancer Metastasis, University of Basel
      address:
         name:Department of Biomedicine, Cancer Metastasis, University of Basel, Basel, Switzerland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sofia Gkountela
      affiliation:
            name:Cancer Metastasis, University of Basel
            address:
               name:Department of Biomedicine, Cancer Metastasis, University of Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      name:Nicola Aceto
      url:http://orcid.org/0000-0001-9579-6918
      affiliation:
            name:Cancer Metastasis, University of Basel
            address:
               name:Department of Biomedicine, Cancer Metastasis, University of Basel, Basel, Switzerland
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Biomedicine, Cancer Metastasis, University of Basel, Basel, Switzerland
      name:Department of Biomedicine, Cancer Metastasis, University of Basel, Basel, Switzerland

External Links {🔗}(307)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.06s.